0001438133-24-000097.txt : 20240517
0001438133-24-000097.hdr.sgml : 20240517
20240517174605
ACCESSION NUMBER: 0001438133-24-000097
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240515
FILED AS OF DATE: 20240517
DATE AS OF CHANGE: 20240517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leal James
CENTRAL INDEX KEY: 0001866570
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36189
FILM NUMBER: 24961620
MAIL ADDRESS:
STREET 1: C/O TANDEM DIABETES CARE, INC.
STREET 2: 11075 ROSELLE STREET
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC
CENTRAL INDEX KEY: 0001438133
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 204327508
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
CITY: San Diego
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-366-6900
MAIL ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
CITY: San Diego
STATE: CA
ZIP: 92130
4
1
wk-form4_1715982353.xml
FORM 4
X0508
4
2024-05-15
0
0001438133
TANDEM DIABETES CARE INC
TNDM
0001866570
Leal James
12400 HIGH BLUFF DRIVE
SAN DIEGO
CA
92130
0
1
0
0
Chief Manufacturing Officer
0
Common Stock
2024-05-15
4
A
0
590
15.64
A
11406
D
Common Stock
2024-05-15
4
M
0
168
0
A
11574
D
Common Stock
2024-05-15
4
F
0
70
47.37
D
11504
D
Common Stock
2024-05-15
4
M
0
806
0
A
12310
D
Common Stock
2024-05-15
4
F
0
334
47.37
D
11976
D
Common Stock
2024-05-15
4
M
0
2299
0
A
14275
D
Common Stock
2024-05-15
4
F
0
951
47.37
D
13324
D
Common Stock
2024-05-15
4
M
0
5748
0
A
19072
D
Common Stock
2024-05-15
4
F
0
2377
47.37
D
16695
D
Restricted Stock Unit
2024-05-15
4
M
0
168
0
D
Common Stock
168
670
D
Restricted Stock Unit
2024-05-15
4
M
0
806
0
D
Common Stock
806
3223
D
Restricted Stock Unit
2024-05-15
4
M
0
2299
0
D
Common Stock
2299
4599
D
Restricted Stock Unit
2024-05-15
4
M
0
5748
0
D
Common Stock
5748
11497
D
The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 16, 2023 through May 15, 2024. This transaction is also exempt under Rule 16b-3(c).
Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.
Awarded on May 25, 2022 pursuant to the 2013 Plan.
RSU vest as to thiry-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Awarded on May 15, 2023 pursuant to the 2013 Plan.
RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).
Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
/s/ Rachel Malina, Attorney-in-Fact for James A. Leal
2024-05-17